American Heart Journal
Volume 156, Issue 3 , Pages 473-476 , September 2008

Three life-years gained from smoking cessation after coronary artery bypass surgery: A 30-year follow-up study

Received 20 July 2007 ,Accepted 9 April 2008.

References 

  1. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994;309:901–911
  2. Jousilahti P, Vartiainen E, Korhonen HJ, et al. Is the effect of smoking on the risk for coronary heart disease even stronger than was previously thought?. J Cardiovasc Risk. 1999;6:293–298
  3. Rosenberg L, Kaufman DW, Helmrich SP, et al. Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA. 1985;253:2965–2969
  4. Wilhelmsson C, Vedin JA, Elmfeldt D, et al. Smoking and myocardial infarction. Lancet. 1975;1:415–420
  5. Hartz AJ, Barboriak PN, Anderson AJ, et al. Smoking, coronary artery occlusion, and nonfatal myocardial infarction. JAMA. 1981;246:851–853
  6. Mulcahy R, Hickey N, Graham IM, et al. Factors affecting the 5 year survival rate of men following acute coronary heart disease. Am Heart J. 1977;93:556–559
  7. Barbash GI, Reiner J, White HD, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995;26:1222–1229
  8. Van Domburg RT, Meeter K, van Berkel DF, et al. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol. 2000;36:878–883
  9. Hasdai D, Garratt KN, Grill DE, et al. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med. 1997;336:755–761
  10. Johansson S, Bergstrand R, Pennert K, et al. Cessation of smoking after myocardial infarction in women. Effects on mortality and reinfarctions. Am J Epidemiol. 1985;121:823–831
  11. Laird-Meeter K, Penn OC, Haalebos MM, et al. Survival in 1041 patients with consecutive aorto-coronary bypass operations. Eur Heart J. 1984;5:35–42
  12. Laird-Meeter K, van Domburg R, Bos E, et al. Survival at 5 to 10 years after aorto-coronary bypass operations in 1041 consecutive patients. Eur Heart J. 1987;8:449–456
  13. Veldkamp RF, Valk SD, van Domburg RT, et al. Mortality and repeat interventions up until 20 years after aorto-coronary bypass surgery with saphenous vein grafts. A follow-up study of 1041 patients. Eur Heart J. 2000;21:747–753
  14. Van Domburg RT, Sonnenschein K, Nieuwlaat R, et al. Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. J Am Coll Cardiol. 2005;46:15–20
  15. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86
  16. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ. 2000;321:983–986
  17. Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000;355:1575–1581
  18. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86–97
  19. Van Berkel TF, Boersma H, Roos-Hesselink JW, et al. Impact of smoking cessation and smoking interventions in patients with coronary heart disease. Eur Heart J. 1999;20:1773–1782
  20. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10:S1–S10
  21. Rice VH, Templin T, Fox DH, et al. Social context variables as predictors of smoking cessation. Tob Control. 1996;5:280–285
  22. Scholte op Reimer W, de Swart E, De Bacquer D, et al. Smoking behaviour in European patients with established coronary heart disease. Eur Heart J. 2006;27:35–41

PII: S0002-8703(08)00285-8

doi: 10.1016/j.ahj.2008.04.007

American Heart Journal
Volume 156, Issue 3 , Pages 473-476 , September 2008

Article Tools

* Image Usage & Resolution